Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Urology
|
March 2, 2019
Novel Scrotal Reconstruction after Fournier's Gangrene Using the Integra™ Dermal Regeneration Template
David W Barham, Mark Y Lee, Danielle A Stackhouse
Urology
|
April 13, 2015
Penile Squamous Cell Carcinoma After a Childhood Hypospadias Repair With Bladder Mucosa Graft
Raffaella DeRosa, Danielle A Stackhouse, Leah P McMann, et al.
Urology
|
January 7, 2015
Impact of the 2012 American Urological Association vasectomy guidelines on postvasectomy outcomes in a military population
Raffaella DeRosa, Michael B Lustik, Danielle A Stackhouse, et al.
Urology
|
April 19, 2006
Fibrin sealant as tissue glue: preliminary experience in complex genital reconstructive surgery
Michael S Morris, Allen F Morey, Danielle A Stackhouse, et al.
Therapeutic Advances in Medical Oncology
|
July 27, 2011
Risk stratification in the hormonal treatment of patients with prostate cancer
Matthew A Uhlman, Judd W Moul, Ping Tang, et al.
The Journal of Urology
|
January 22, 2010
Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostate
Matthew A Uhlman, Leon Sun, Danielle A Stackhouse, et al.
Urology
|
October 13, 2009
Tumor volume, tumor percentage involvement, or prostate volume: which is predictive of prostate-specific antigen recurrence?
Matthew A Uhlman, Leon Sun, Danielle A Stackhouse, et al.
Urology
|
June 9, 2009
Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?
Arthur A Caire, Leon Sun, Oludotun Ode, et al.
The Journal of Urology
|
September 18, 2009
Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras
Leon Sun, Arthur A Caire, Cary N Robertson, et al.
Urology
|
October 10, 2009
Public survey and survival data do not support recommendations to discontinue prostate-specific antigen screening in men at age 75
Arthur A Caire, Leon Sun, Cary N Robertson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Urology
|
March 2, 2019
Novel Scrotal Reconstruction after Fournier's Gangrene Using the Integra™ Dermal Regeneration Template
David W Barham, Mark Y Lee, Danielle A Stackhouse
Urology
|
April 13, 2015
Penile Squamous Cell Carcinoma After a Childhood Hypospadias Repair With Bladder Mucosa Graft
Raffaella DeRosa, Danielle A Stackhouse, Leah P McMann, et al.
Urology
|
January 7, 2015
Impact of the 2012 American Urological Association vasectomy guidelines on postvasectomy outcomes in a military population
Raffaella DeRosa, Michael B Lustik, Danielle A Stackhouse, et al.
Urology
|
April 19, 2006
Fibrin sealant as tissue glue: preliminary experience in complex genital reconstructive surgery
Michael S Morris, Allen F Morey, Danielle A Stackhouse, et al.
Therapeutic Advances in Medical Oncology
|
July 27, 2011
Risk stratification in the hormonal treatment of patients with prostate cancer
Matthew A Uhlman, Judd W Moul, Ping Tang, et al.
The Journal of Urology
|
January 22, 2010
Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostate
Matthew A Uhlman, Leon Sun, Danielle A Stackhouse, et al.
Urology
|
October 13, 2009
Tumor volume, tumor percentage involvement, or prostate volume: which is predictive of prostate-specific antigen recurrence?
Matthew A Uhlman, Leon Sun, Danielle A Stackhouse, et al.
Urology
|
June 9, 2009
Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?
Arthur A Caire, Leon Sun, Oludotun Ode, et al.
The Journal of Urology
|
September 18, 2009
Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras
Leon Sun, Arthur A Caire, Cary N Robertson, et al.
Urology
|
October 10, 2009
Public survey and survival data do not support recommendations to discontinue prostate-specific antigen screening in men at age 75
Arthur A Caire, Leon Sun, Cary N Robertson, et al.
Page
of 2